AC Immune SA (ACIU) Stock Statistics & Valuation Metrics

AC Immune SA has a market cap or net worth of $160.29M. The enterprise value is $29.03M.

AC Immune SA has 98,943,130 shares outstanding. The number of shares has decreased by -2.65% in one year.

AC Immune SA’s return on equity (ROE) is -0.45 and return on invested capital (ROIC) is -39.95%.

The current PE Ratio of AC Immune SA is -4.80. AC Immune SA’s PEG ratio is 0.24.

In the last 12 months, AC Immune SA had revenue of 27.31M and earned -50.92M in profits. Earnings per share was -0.51.

In the last 12 months, operating cash flow was 46.00M and capital expenditures -689.00K, giving a free cash flow of 45.31M billion.

AC Immune SA pays an annual dividend of ―, resulting in a dividend yield of ―

AC Immune SA upcoming earnings date is Aug 6, 2025, TBA Not Confirmed.

AC Immune SA as a current ratio of 1.71, with Debt / Equity ratio of 5.46%

In the past 12 months, AC Immune SA has paid 3.00K in taxes.

AC Immune SA EV to EBITDA ratio is -4.39, with an EV/FCF ratio of 3.27.

AC Immune SA has $145.61M in cash and marketable securities with CHF5.17M in debt, giving a net cash position of -$140.44M billion.

Gross margin is 39.44%, with operating margin of -191.80%, and net profit margin of -186.44%.

The average price target for AC Immune SA is $9.67, which is 11.43% higher than the current price. The consensus rating is Strong Buy